IceCure Medical ICCM
NASDAQ ICCM
$1.62 +0.03 (+1.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

IceCure Medical (ICCM) Current Deferred Revenue (2022 - 2025)

Updated

IceCure Medical's Current Deferred Revenue came in at $255,000 for Q4 2025, down 23.7% from $334,000 a year earlier.

Analysis

IceCure Medical (ICCM) Current Deferred Revenue (2022 - 2025) Analysis & Trends

Going back to Q4 2022, IceCure Medical's Current Deferred Revenue data covers 4 quarters.

  • Current Deferred Revenue carries a three-year compound annual growth rate of -26.6% (FY2022 to FY2025).
  • Going back by year, Current Deferred Revenue was $334,000 in FY2024 (+78.6%), $187,000 in FY2023 (-71.1%) and $646,000 in FY2022.
  • The Q4 2025 figure represents the lowest quarterly Current Deferred Revenue since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 IceCure Medical 3.95 Mn -35.10 Mn 253,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 255,000.00
Dec 31, 2024 334,000.00
Dec 31, 2023 187,000.00
Dec 31, 2022 646,000.00
API Access

IceCure Medical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ICCM&period=max&api_key=YOUR_API_KEY